24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiomX
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:00
Israeli AI startup REplace raises $2.1M to accelerate clean energy deployment with site selection platform
15:35
Telegram's $1.745 billion bond sale severely oversubscribed
15:15
Empathy raises $72M Series C to streamline grief support and estate management
14:31
Full list of Israeli high-tech funding rounds in 2025
More stories
Buzz
Most popular
Daily
Weekly
1
Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security
2
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
3
Buildots raises $45M at $300M valuation to modernize global construction with AI
4
Guardicore founders raise $32 million for new stealth cyber-AI startup
5
Syte files for court protection after burning through $70 million in funding
More news
BiomX
3 stories about BiomX
Biomed Company BiomX Merges With New York-Listed Chardan Healthcare
17.07.19
|
Meir Orbach
BiomX develops customized therapies for conditions such as acne and inflammatory bowel disease
Phage Therapies Company BiomX Raises $32 Million
20.02.19
|
Amarelle Wenkert
BiomX develops customized therapies based on bacteriophages—viruses that invade bacterial cells and can be used to treat infections
Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration
13.12.18
|
Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics